skip to main content

Endometrial Cancer — SCE Medical Oncology MCQ

Instant feedback + full explanation. One question, done properly.

HardGynaecological CancersEndometrial CancerSCE Medical Oncology

After hysterectomy, pathology shows grade 1 endometrioid endometrial carcinoma with cervical stromal invasion, less than 50% myometrial invasion and no substantial LVSI. Molecular testing shows NSMP. Under FIGO 2023, which anatomical stage descriptor is correct?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CStage IIA because non-aggressive histology involves the cervical stroma

FIGO 2023 assigns non-aggressive histology with cervical stromal invasion to stage IIA. Stage IIB is substantial LVSI, not cervical invasion. IA2 is low-grade disease with less than 50% myometrial invasion only when the stage-II feature is absent; IB and IIIC1 do not fit.

Reference: FIGO staging of endometrial cancer 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10482588/